COVID-19 vaccination rate in Moldova at 12.7%

Since the COVID-19 vaccination campaign was kicked off in the Republic of Moldova, almost 697,000 doses have been administered in the country. The rate of vaccination with the first dose is 12.7%, while with both of the doses – 7.6%. During June 21-27, the number of vaccinations with the first dose doubled compared with a week before, IPN reports.

In a news conference on June 29, specialists of the National Public Health Agency said that of all the vaccinated persons, 47% are woman, while 53% are men. There were reported 1,425 adverse events following immunization. Of these, 93% were mild forms, while almost 7% were moderate forms.

Secretary of state at the Ministry of Health, Labor and Social Protection Igor Curov called on the population to get vaccinated given that the Delta variant has spread to many countries, whereas the available vaccines are effective against this strain too. “Regrettably, the citizens who weren’t vaccinated develop serious forms,” noted Igor Curov.

The official also said that the first samples to detect the Indian variant (Delta) of SARS-CoV-2 in Moldova were transmitted to Germany for sequencing. The results will be presented in the near future. There will be collected more samples yet.

So far Moldova received over 1 million COVID-19 vaccine doses and over half of them were Astra Zeneca doses.

Igor Curov noted that the process of procuring the 700,000 Pfizer vaccine doses is at the final phase and the discussions not center on delivery. The authorities are also negotiating the purchase of a lot of 700,000 Sputnik V vaccine doses, but the process is slow owing to the difficulties related to the capacities of the producer. 

Moldova by June 28 got 256,614 infections with the novel coronavirus. The death toll from COVID-19 stands at 6,187.

Вы используете модуль ADS Blocker .
IPN поддерживается от рекламы.
Поддержи свободную прессу!
Некоторые функции могут быть заблокированы, отключите модуль ADS Blocker .
Спасибо за понимание!
Команда IPN.